Hussman Strategic Advisors’s Pediatrix Medical MD Stock Holding History

Hussman Strategic Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Hold	63,000	–	–	0.37%	131
2026 Q1	$1.35M	Buy	+63,000	New	+$1.31M	0.29%	157
2025 Q4	–	Sell	-168,000	Closed	-$2.81M	–	324
2025 Q3	$2.81M	Sell	168,000 -42,000	-20%	-$629K	0.61%	42
2025 Q2	$3.01M	Buy	210,000 +126,000	+150%	+$1.73M	0.69%	48
2025 Q1	$1.22M	Buy	+84,000	New	+$1.19M	0.3%	134
2022 Q1	–	Sell	-26,000	Closed	-$707K	–	341
2021 Q4	$707K	Buy	+26,000	New	+$696K	0.16%	205
2021 Q2	–	Sell	-7,200	Closed	-$183K	–	369
2021 Q1	$183K	Buy	+7,200	New	+$184K	0.04%	312
2019 Q1	–	Sell	-1,700	Closed	-$56K	–	260
2018 Q4	$56K	Buy	+1,700	New	+$68.3K	0.01%	224
2015 Q4	–	Sell	-30,000	Closed	-$2.3M	–	222
2015 Q3	$2.3M	Buy	+30,000	New	+$2.42M	0.29%	118

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Hussman Strategic Advisors's MD Position: Q2 2026 in Review

Hussman Strategic Advisors held its Pediatrix Medical (MD) position steady in Q2 2026 at 63,000 shares worth $1.6M. The position accounts for 0.37% of the portfolio, ranked #131.

Hussman Strategic Advisors first reported a position in MD in Q3 2015 and has held it in 9 quarters since. The position peaked at $3.01M in Q2 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Hussman Strategic Advisors held 63,000 shares of Pediatrix Medical worth $1.6M as of Q2 2026.
Hussman Strategic Advisors left its Pediatrix Medical share count unchanged in Q2 2026.
Pediatrix Medical made up 0.37% of Hussman Strategic Advisors's portfolio in Q2 2026, its #131 holding.
Hussman Strategic Advisors first reported a position in Pediatrix Medical in Q3 2015 and has held it in 9 quarters since.
Hussman Strategic Advisors's Pediatrix Medical position peaked at $3.01M in Q2 2025.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.